Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Current Medicinal Chemistry|February 20, 2010
GPR55: Current knowledge and future perspectives of a purported "Type-3" cannabinoid receptorAlessio Moriconi, Ilaria Cerbara, Mauro Maccarrone, et al.Bioorganic & Medicinal Chemistry|March 6, 2012
In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitorsAlessandra Topai, Perla Breccia, Franco Minissi, et al.Journal of Medicinal Chemistry|February 7, 2003
3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-alkylamides as a new class of synthetic histone deacetylase inhibitors. 1. Design, synthesis, biological evaluation, and binding mode studies performed through three different docking proceduresAntonello Mai, Silvio Massa, Rino Ragno, et al.Journal of Medicinal Chemistry|May 21, 2009
Thiopyrophosphoantigens: solid-phase synthesis and in vitro characterization of a new class of Vgamma9 Vdelta2 T cells activatorsPerla Breccia, Francesca Angeli, Ilaria Cerbara, et al.Medicinal Research Reviews|February 18, 2005
Histone deacetylation in epigenetics: an attractive target for anticancer therapyAntonello Mai, Silvio Massa, Dante Rotili, et al.Journal of Medicinal Chemistry|February 20, 2004
3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 2. Effect of pyrrole-C2 and/or -C4 substitutions on biological activityAntonello Mai, Silvio Massa, Ilaria Cerbara, et al.Journal of Medicinal Chemistry|March 5, 2004
3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 3. Discovery of novel lead compounds through structure-based drug design and docking studiesRino Ragno, Antonello Mai, Silvio Massa, et al.Current Medicinal Chemistry|September 11, 2008
Structural bases for substrate and inhibitor recognition by matrix metalloproteinasesLoretta Aureli, Magda Gioia, Ilaria Cerbara, et al.Pageof 1